InDevR spins off ViroCyt, raises growth capital

Wednesday, January 16, 2013

ViroCyt, a privately held life science company, has begun operations after spinning off from InDevR, a developer of advanced life science instrumentation and assays. Concurrent with the formation of ViroCyt, funding was secured from a group of investors led by High Country Venture.

[Read More]